These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 24134930)

  • 1. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.
    Stewart CJ; Alexiadis M; Crook ML; Fuller PJ
    Hum Pathol; 2013 Dec; 44(12):2774-81. PubMed ID: 24134930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
    Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
    Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
    Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
    Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
    Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
    Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
    Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
    Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.
    McCluggage WG; McKenna M; McBride HA
    Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.
    Cathro HP; Stoler MH
    Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
    Oliva E; Garcia-Miralles N; Vu Q; Young RH
    Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
    Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
    Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin.
    Deavers MT; Malpica A; Liu J; Broaddus R; Silva EG
    Mod Pathol; 2003 Jun; 16(6):584-90. PubMed ID: 12808064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
    Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
    Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of molecular analysis in differential diagnosis of ovarian adult granulosa cell tumors].
    Zheng XZ; Ma JH; Chen TB; Xu F; Zou ZY; Zhang LH; Jin YL; Zhan Y
    Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):794-799. PubMed ID: 32746545
    [No Abstract]   [Full Text] [Related]  

  • 13. FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumors.
    Chiang S; Staats PN; Senz J; Kommoss F; De Nictolis M; Huntsman DG; Gilks CB; Oliva E
    Am J Surg Pathol; 2015 May; 39(5):618-23. PubMed ID: 25581731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network.
    Maillet D; Goulvent T; Rimokh R; Vacher-Lavenu MC; Pautier P; Alexandre J; Pujade-Laurraine E; Devouassoux-Shisheboran M; Treilleux I; Ray-Coquard I; Savina A
    Gynecol Oncol; 2014 Jan; 132(1):181-7. PubMed ID: 24157616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry of unclassified sex cord-stromal tumors of the testis with a predominance of spindle cells.
    Renshaw AA; Gordon M; Corless CL
    Mod Pathol; 1997 Jul; 10(7):693-700. PubMed ID: 9237180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of mutation of DICER1 and FOXL2 genes in microcystic stromal tumor of the ovary.
    Meurgey A; Descotes F; Mery-Lamarche E; Devouassoux-Shisheboran M
    Virchows Arch; 2017 Feb; 470(2):225-229. PubMed ID: 27830327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and genomics of ovarian sex cord-stromal tumors.
    Fuller PJ; Leung D; Chu S
    Clin Genet; 2017 Feb; 91(2):285-291. PubMed ID: 27813081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
    Young RH
    Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
    Wessman S; Fuentes BB; Severin-Karlsson J; Westbom-Fremer S; Nistér M; Kokaraki G; Petta TB; Haglund F; Carlson JW
    Int J Gynecol Pathol; 2024 Jan; 43(1):78-89. PubMed ID: 37255476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3 sigma is a useful immunohistochemical marker for diagnosing ovarian granulosa cell tumors and steroid cell tumors.
    Chen L; Yang B
    Int J Gynecol Pathol; 2013 Mar; 32(2):156-62. PubMed ID: 23370648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.